Status:

ACTIVE_NOT_RECRUITING

TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects

Lead Sponsor:

University Medical Center Groningen

Collaborating Sponsors:

The Netherlands Cancer Institute

Conditions:

Testicular Cancer

Eligibility:

MALE

18-75 years

Brief Summary

Testicular cancer (TC) is a rare disease, which mostly affects young men aged 15-35 years. Their life expectancy has greatly improved due to the introduction of platinum-containing chemotherapy for di...

Detailed Description

Design: The investigators will perform a multicenter case-cohort study. Patients treated for TC who developed cardiac disease ((either myocardial infarction, proven coronary artery disease (grade ≥2) ...

Eligibility Criteria

Inclusion

  • All participating patients have to meet the following criteria:
  • Alive
  • TC diagnosis between 01-01-1976 to 31-12-2007
  • TC treatment center: UMCG, NKI/AVL, Erasmus MC, UMCN, LUMC
  • Younger than 50 years of age at TC diagnosis
  • Written informed consent
  • Cases have to fulfill, beside the aforementioned criteria, the following criteria:
  • Diagnosed with either myocardial infarction (MI), proven coronary artery disease (CAD) (CTCAE-4 grade 2 or higher) or congestive heart failure (CHF) (CTCAE-4 grade 2 or higher).
  • No medical history of CVD before diagnosis of TC
  • In order to be eligible to participate in the cardiometabolic risk inventory study (and to be invited to a study assessment), a subject must meet, next to the criteria mentioned in "1)", the following inclusion criteria:
  • Younger than 40 years of age at TC diagnosis
  • Younger than 75 years of age at moment of inclusion
  • Exclusion criteria:
  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Mental disorder (no informed consent available)
  • Presence of active malignant disease

Exclusion

    Key Trial Info

    Start Date :

    July 1 2014

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    April 1 2026

    Estimated Enrollment :

    939 Patients enrolled

    Trial Details

    Trial ID

    NCT02276430

    Start Date

    July 1 2014

    End Date

    April 1 2026

    Last Update

    September 15 2025

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Antoni van Leeuwenhoek Hospital

    Amsterdam, Netherlands

    2

    University Medical Center Groningen

    Groningen, Netherlands, 9700 RB

    3

    University Medical Center St. Radboud

    Nijmegen, Netherlands